Catalyst Wire Dossier Catalyst Wire Dossier

Selnoflast

· Genentech, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Selnoflast, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events [Phase 2]

See pricing